Skip to content

State government: pharmaceuticals: procurement: collaborative.

This bill did not become law and its session has ended, so it can no longer move. It would have to be reintroduced.

CA AB 587 · Assembly Bill · 2017–2018

Stage
Session ended
Started in
Assembly
Sponsor
1
Latest action
Aug 21, 2017

What it does

Existing law requires specified state agencies to participate in a prescription drug bulk purchasing program, authorizes the Department of General Services to enter into exclusive or nonexclusive contracts on a bid or negotiated basis with manufacturers and suppliers of single-source or multisource drugs and to obtain from those manufacturers and suppliers discounts, rebates, or refunds based on quantities purchased insofar as permissible under federal law, and authorizes the department to appoint and contract with a pharmaceutical benefits manager, as specified. Existing law authorizes the Department of General Services to explore additional strategies for managing prescription drug costs…

Read the full text

Where it stands

This bill did not become law and its session has ended, so it can no longer move. It would have to be reintroduced.

  1. Introduced (Done)

  2. Committee (Done)

  3. Floor (Current step)

    Passed first chamber · Aug 21, 2017

  4. Law (Needs attention)

    The session ended first

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money in California.

Work with this bill

State government: pharmaceuticals: procurement: collaborative. | 52